Societies

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Photo taken from Moderna/LinkedIn

Apr 9, 2024, 16:41

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Quoting Moderna on LinkedIn:

“Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types, harnessing the body’s immune system to identify and kill cancer cells.

We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.

Join us at AACR24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients.”

Source: Moderna/LinkedIn

AACR24 cancer Cancer research cancer therapies cancer treatment Innovation Medical Advancements Medical Technology mmuno-oncology Moderna mRNA OncoDaily Oncology San Diego

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage